瘦素调控大鼠肝纤维化的信号转导机制及保肝宁的干预作用
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
科研工作来源:国家自然基金资助项目(30672769);广东省中医药局资助项目(1050128)。
     研究背景:肝纤维化(hepatic fibrosis,HF)主要是由肝脏内细胞外基质(extracellular matrix,ECM)的合成大于降解,致使ECM在肝脏内过度沉积所致。它是大多数慢性肝病所共有的病理特征,也是慢性肝炎、肝硬化等进一步发展、恶化的重要中间环节。据统计,我国患慢性乙型肝炎的病人超过3000万,每年死于肝炎后肝硬化者有40万人,而治愈肝硬化的唯一途径是阻断肝纤维化。迄今为止,全世界包括我国在内的国家尚没有批准一个抗纤维化西药,中医药抗肝纤维化的实验和临床研究已凸现其特有的优势,其中尤以复方中药抗肝纤维化的多靶点治疗作用更为引人注目。
     我们在全面认识慢性肝病肝纤维化病因病机的基础上,研制出抗肝纤维化新方保肝宁,它寓疏肝解郁、益气健脾;活血化瘀、软坚散结;兼清热利湿解毒等重要治法于一体,应用于临床,疗效卓著。在国家自然科学基金、广东省自然科学基金的资助下,我们开展了保肝宁抗肝纤维化的信号转导机制研究。保肝宁抑制HSC增殖作用可能与NF-κB信号转导通路有关,保肝宁能明显降低HSC细胞NF-κB的表及IκB的磷酸化。
     瘦素(Leptin)是新发现的促肝纤维化的细胞因子,目前对瘦素促肝纤维化的分子机制研究,国外刚刚起步,国内相关文献报道更加少有。因此,我们认为系统的研究瘦素及其信号转导机制,并在此基础上探讨中药保肝宁对瘦素、瘦素受体及受体后介导的信号转导通路的影响,有助于进一步阐明其抗肝纤维化的作用途径和作用靶点,为保肝宁防治和逆转肝纤维化提供更加充分的理论依据,同时,对于深化和完善肝纤维化的机制研究具有十分重要的理论意义。
     目的和意义:探讨保肝宁抗肝纤维化的分子机制,为保肝宁应用于临床提供充分的理论依据,为开发抗肝纤维化新药保肝宁奠定坚实的理论基础。
     研究方法:以复合因素诱导的肝纤维化模型大鼠为研究对象,观察保肝宁(方药由黄芪、桃仁、丹参、黄芩、鳖甲等组成)对模型大鼠瘦素及其信号转导通路的影响。
     50只Wistar大鼠随机分为5组,即正常对照组(A组)、模型组(B组)、秋水仙碱组(C组)、保肝宁大剂量组(D组)、保肝宁中剂量组(E组)。除A组外,其余大鼠于实验第1d每只皮下注射40%(体积分数)CCl_4花生油0.5ml·100g~(-1);以后每3日注射0.3ml·100g~(-1)。除A组外,各组均以普通饲料喂养,并以5%乙醇为饮料。A组注射等量花生油,进食普通饲料并自由饮水。各组从造模第2天开始,每日给相应药物灌胃,C组每日灌服秋水仙碱0.011mg·100g~(-1),D、E组分别每日灌服保肝宁3.54g·100g~(-1)、1.77g·100g~(-1),B组及A组灌以等量蒸馏水作对照。第6厨末,处死动物,取血和肝组织备用。取新鲜肝组织梯度置于-70℃中保存,用于蛋白印迹实验(Western blotting analysis);一部分肝组织固定于10%中性福尔马林溶液,肝组织常规脱水,石蜡包埋,切片厚5μm,做光镜观察和免疫组化用;血清谷丙转氨酶(ALT)和谷草转氨酶(AST)活性;总胆固醇(TC)、甘油三脂(TG)采用全自动生化分析仪检测;放免法测定血清瘦素(Leptin)水平;光学显微镜下观察肝组织病理学变化;免疫组织化学技术检测瘦素(Leptin)及瘦素受体(OB-Rb)等的表水平;应用蛋白印迹试验(Western blotting analysis)检测瘦素受体(OB-Rb),JAK2(Janus激酶,Januskinase)和转录活化因子(STAT3)蛋白的表水平以及它们的磷酸化水平。统计学处理:计量资料用平均值±标准差(x±s)表示,数据处理采用SPSS14.0统计软件包进行单因素方差分析(one-way ANOVA)。
     研究内容和过程:
     1.观察保肝宁对模型大鼠的症状、体征及肝、脾指数的影响
     模型组大鼠精神不振、消瘦、厌食,饮水减少,大便稀溏,小便色黄而少;肝脏表面较正常组欠光滑,颜色浅,边缘钝,质地硬,部分标本表面凹凸不平,呈小结节状;脾脏明显肿大,呈暗红色。各药物组大鼠精神状态、毛色泽、饮食饮水、排便等一般情况均明显改善,以保肝宁各组改善情况为佳。在增加体重方面,与模型组比较,秋水仙碱、保肝宁大、中剂量均能显著增加大鼠体重(P<0.05、P<0.01、P<0.01);各药物组比较差异无显著性意义(p>0.05)。各药物组大鼠肝脏表面较光滑,颜色较红;脾脏与正常组大鼠相比较无明显差异。与正常组比较,模型组、各药物组肝指数均明显增加,差异有非常显著性意义(P均<0.01),模型组脾脏指数亦明显升高,差异有非常显著性意义(P均<0.01);与模型组比较,各药物组均能显著降低模型大鼠肝、脾指数,差异有显著性意义(P均<0.01);其中,保肝宁大剂量组降低肝指数的作用明显优于秋水仙碱组,差异有显著性意义(p<0.05)。
     2.观察保肝宁对肝纤维化大鼠肝组织形态学的影响
     光镜观察显示:模型组正常肝小叶结构破坏,肝索排列紊乱,可见肝细胞点状坏死,肝细胞空泡变性散在分布,间质增生明显,胶原纤维构成的纤维间隔形成,形成较多完整的假小叶。各药物组肝小叶样结构明显改善,胶原纤维间隔较少,肝细胞坏死、炎性细胞浸润少见,但极少数大鼠仍有不完全性假小叶。
     3.保肝宁对模型大鼠血清肝功能、血脂的影响
     与正常组比较,模型组血清ALT、AST、AST/ALT比值均明显升高(P均<0.01),各药物组ALT、AST水平亦明显升高(P均<0.01);与模型组比较,各药物组血清ALT、AST活性明显下降,差异有非常显著性意义(P均<0.01),保肝宁中剂量组AST/ALT比值也明显下降,差异有显著性意义(P<0.05);保肝宁大剂量组降低AST作用明显优于秋水仙碱(P<0.05)。与正常组比较,模型组及各药物组血清TC、TG水平明显下降,差异有非常显著性意义(P<0.01);与模型组比较,保肝宁大、中剂量组血清TC、TG水平明显升高,差异有非常显著性意义(P均<0.01)。其中,保肝宁大剂量升高TC作用明显明显优于秋水仙碱组(P<0.05),保肝宁大、中剂量组升高TG作用均明显优于秋水仙碱组(P均<0.05)。
     4.保肝宁对模型大鼠血清瘦素(Leptin)水平的影响
     与正常组比较,模型组及各药物组血清Leptin水平明显升高,差异有非常显著性意义(P<0.01);与模型组比较,各药物组则明显下降(P<0.01、P<0.01、P<0.05);各药物组降低Leptin作用,差异无显著性意义(P>0.05)。
     5.保肝宁对肝纤维化大鼠肝组织瘦素(Leptin)及瘦素受体(OB-Rb)的影响
     (1)Leptin的表:正常组肝细胞内呈阴性或极弱阳性表,偶见于汇管区、小叶中央静脉周围及肝索Disse腔间隙中。模型组肝内Leptin表明显增强,数目增多,呈棕黄色胞质型分布;小叶中央静脉周围、汇管区及肝小叶内均有大量条索状、星芒状瘦素阳性表,高倍镜下,阳性表主要分布于HSC胞质中。各药物组阳性染色程度较模型组明显减轻,阳性细胞数目减少。统计学显示,与正常组比较,模型组、各药物组Leptin表明显增多,差异有非常显著性意义(P<0.01);与模型组比较,各药物组均可以降低Leptin的表,差异有显著性意义(p<0.01);各药物组两两比较差异无显著性意义(P>0.05)。
     (2)OB-Rb表:正常组肝细胞内呈阴性或极弱阳性表,偶见于汇管区、小叶中央静脉周围及肝索Disse腔间隙中。模型组肝内表明显增强,数目增多,呈棕黄色胞质型分布;高倍镜下,阳性表主要分布于非实质细胞(包括肝星状细胞、窦内皮细胞、枯否细胞等)胞质及胞膜上,部分可定位于核。统计学显示,与正常组比较,模型组、各药物组OB-Rb表明显增多,差异有显著性意义(P均<0.01);与模型组比较,各药物组OB-Rb表均无明显变化,差异无显著性意义(P均>0.05);各药物组OB-Rb的表两两比较差异无显著性意义(P>0.05)。
     6.保肝宁对肝纤维化大鼠肝组织瘦素受体(OB-Rb)及其JAK2-STAT3信号转导通路的影响
     (1)OB-Rb、JAK2、STAT3蛋白表。用Western Blot法检测肝脏组织细胞内OB—-b、JAK2、STAT3蛋白表情况,正常组蛋白表量最少,保肝宁和秋水仙碱处理组蛋白条带颜色均较浅,模型组条带颜色最深。与正常组比较,模型组、保肝宁大、中剂量组和秋水仙碱组OB-Rb、JAK2、STAT3蛋白程度均增高;与模型组相比,各药物组的OB-Rb、JAK2、STAT3蛋白表显著降低;保肝宁大、中剂量组和秋水仙碱组相比,OB-Rb、JAK2、STAT3蛋白显著降低。
     (2)JAK2、STAT3蛋白磷酸化水平。用Western Blot法检测肝脏组织细胞内JAK2、STAT3蛋白磷酸化水平,正常组蛋白磷酸化水平最低,保肝宁和秋水仙碱处理组蛋白条带颜色均较浅,模型组条带颜色最深。与正常组比较,模型组、各药物组P-JAK2、P-STAT3蛋白表水平均增高;与模型组相比,各药物组的P-JAK2、P-STAT3蛋白表显著降低;保肝宁大、中剂量组和秋水仙碱组相比,P-JAK2、P-STAT3蛋白水平显著降低。
     结论:保肝宁能有效的阻止模型大鼠肝纤维化进程,其作用机制为:
     1.保肝宁可以有效的改善肝纤维化模型大鼠的一般情况:如改善模型大鼠的精神状况,增加体重,改善食欲和饮水等症状,提高大鼠生存质量;显著降低模型大鼠肝、脾指数。
     2.形态学观察表明保肝宁能明显改善破坏的肝小叶结构,减轻纤维组织增生;明显减少胶原纤维间隔、肝细胞坏死以及炎性细胞的浸润等。
     3.保肝宁明显降低纤维化模型大鼠血清ALT、AST含量,TG、TC水平明显升高,提示保肝宁能有效减轻炎症反应,调节血脂水平,保护肝细胞,从而抑制早期肝纤维化的启动。
     4.保肝宁明显降低纤维化模型大鼠血清Leptin水平,有效的阻止了Leptin与OB-Rb结合而发挥的诱导HSC活化和增殖作用。
     5.保肝宁明显抑制纤维化模型大鼠肝组织Leptin的表,明显减轻Leptin阳性染色程度,减少阳性细胞数目,提示Leptin是保肝宁抗肝纤维化的作用靶点之一。
     6.保肝宁有效抑制纤维化模型大鼠肝组织OB-Rb以及其信号转导分子JAK2、STAT3的蛋白表,显著降低JAK2、STAT3蛋白磷酸化水平,提示保肝宁具有抑制OB-Rb及其信号转导作用,这可能是其抗肝纤维化的分子机制之一。
     综上所述,保肝宁具有综合抗肝纤维化的药理作用,其作用机制为多途径、多靶点。抑制Leptin的表、抑制OB-Rb及其JAK2/STAT3信号转导通路,可能是其抗肝纤维化的分子机制之一。而这一机制与抑制炎症反应,调节血脂水平,保护肝细胞,减少细胞因子所产生的瀑布效应,从而抑制肝纤维化的启动密切相关。
Source of the research work:This research work was funded by National Natural Sciences Fund and Guangdong Medicine Bureau of Guangdong province.
     Research background:Liver fibrosis results from chronic damage to the liver in conjunction with the accumulation of ECM proteins,which is a characteristic of most types of chronic liver diseases and also is the important middle key to chronic hepatitis and deteriorating hepatocirrhosis.According to statistics there are over 30000000 patients suffering from chronic B hepatitis in China.Each year about 400000 patients die of posthepatitic cirrhosis.And the only way to cure hepatocirrhosis is to prevent liver fibrosis.Until now there is no authorized anti-fibrosis drug in the world including China.The clinical and experimental studies on effectiveness of TCM against fibrosis have demonstrated its special advantages. The multi-target mechanisms on anti-fibrosis with compound prescriptions are especially extraordinary.
     Abstract:Aiming at the pathogenesis characteristics of liver stasis and spleen deficiency,blood stasis and damp wet of hepatic fibrosis among chronic liver diseases,we have invented a new formula,Baoganning,which has the functions to relieve stagnancy of the liver Qi,reinforce Qi and invigorate the spleen,promote blood circulation to eliminate stasis,soften and resolve hard masses,concurrently clear up toxic heat and dampness.Clinic and experimental research have confirmed the efficacy of Baoganning in treating liver fibrosis.The main mechanisms are to decrease the inflammation,suppress the proliferation and promote the apoptosis of hepatic stellate cells by inhibiting the expression of nuclear factorκB.
     Leptin is a newly discovered cytokine which promotes liver frbrosis.Currently research on the molecular mechanism of leptin in promoting liver fibrosis has just started overseas and in China there are few publications in this field.Research on the signal transduction mechanism is insufficient and the existing studies are limited to the exsomatized cells.To the author's knowledge there is no open literature about vivo experiments.Therefore we believe research on signal transduction mechanism of leptin to stimulate the HSCs to proliferate in vivo and in vitro has great significance in understanding the mechanisms of liver fibrosis.Investigations on effects of Chinese medicine Baoganning on leptin,leptin-receptor and its signal transduction are helpful in finding the anti-fibrosis working principles.It will also provide the theoretical basis for Baoganning to prevent and treat the liver fibrosis.
     Objectives and purposes:to investigate the molecular mechanism of anti-liver-fibrosis treatment with Baoganning,thus providing a theoretical foundation for applying Baoganning to the clinic,and establishing a solid theoretical platform for developing the traditional Chinese medicine on anti-liver fibrosis.
     Methods:The fibrosis in the rats model was induced by multiple factors.And Baoganning consisting of Chinese herbs Huangqi,Taoren,Danshen,Huangqin,Biejia, etc was given to the rats.The effects of Baoganning on fibrosis were studied.
     Fifty Wistar rats were randomly divided into normal group(A),model group(B), Colchicine group(C),high dose of Baoganning group(D)and medium dose of Baoganning group(E).All rats except rats in group A were subcutaneously injected with 40%carbon tetrachloride in peanut oil with a dose of 0.5ml/100g according to the body weight once on the first day,then with a dose of 0.3ml/100g once every three days for six weeks.Meanwhile,they were fed with normal fodder.5%alcohol was used as drinking water.Rats in group A were subcutaneously injected with equal peanut oil and fed with normal fodder and water.Rats in group C,D and E were respectively given Colchicine(0.011mg/100g),Baoganning(3.54g/100g)and Baoganning(1.77g/100g)per day for six weeks via gastrogarage.Rats in group A and B were served with distilled water at the same time.At the end of the sixth week, blood and tissue specimens were taken from all the rats.Some serum were used for analysis of aspartate transaminase(AST)and alanine transaminase(ALT)activities according to the direction of the kit and others for the analysis of total cholesterol (TC),Triglyceride(TG)with an automatic biochemical machine and leptin(LP)by radioimmunoassay(RIA).Some liver specimens were mixed in a 10%solution of formaldehyde in 0.1 mol/L phosphatobuffered saline,and embedded in paraffin. Five-micron thick sections were prepared to evaluate the degree of fibrosis under an optical microscope and analyze the expression of leptin(LP),leptin receptor(OB-R) and signal transducer and activator transcription 3(STAT3)with immunohistochemistry(IH)methods and western blotting and analysis.As to statistical analysis,data were analyzed with the software of SPSS14.0.Quantitative data were presented as mean±SD and compared using one way ANOVA procedure.
     Results and Discussions:
     1.To observe the influence of Baoganning on symptoms,physical signs and indices(liver wet weight/100g body weight)of liver and spleen(spleen wet weight/100g body weight)in liver fibrosis rat model.
     Rats in model group displayed lassitude,thinness,anorexia and their stool was loose,the urine was yellow and less.The surface of livers in model group was not smooth,the colour was lightly red,the edge was blunt and the quality was hard.There were even some little tubercles on the liver surface.The spleens were obviously swollen.Compared with the rats in the model group,rats in the treatment groups were in better conditions.High and medium dosages of Baoganning and colchicines were effectual in improving weight(P<0.01,P<0.01,P<0.05),There was no major difference between high,medium dosages of Baoganning and colchicines(P>0.05),and all significantly decreased the indices of liver and spleen(P<0.01 in both groups).High dosages of Baoganning were better than colchicines(P<0.05).
     2.To observe the influence of Baoganning on liver morphology in liver fibrosis rat model.
     Under a microscope damaged lobules of liver degeneration,necrosis of liver cells, lots of inflammatory cells,collage fibers and even pseudolobules were observed for the model group,while for the treatment groups there were less damaged lobules of liver degeneration,necrosis of liver cells,inflammatory cells and collage fibers.But there were still incomplete pseudolobules in very few rats.
     3.The effects of Baoganning on serum hepatic function and lipid in liver fibrosis rat model.
     Compared with the normal group,levels of ALT,AST and AST/ALT in the model group went up sharply(P<0.01);Compared with the model group,levels of ALT and AST in treatment groups went down obviously(all P<0.01).The effects of a high dosage of Baoganning on decreasing the levels of AST were also more significant than colchicines(P<0.05);AST/ALT significantly was decreased with medium dosages of Baoganning(P<0.05).
     Compared with the normal group,levels of TC and TG were significantly decreased(P<0.01).Compared with the model group,levels of TC and TG with high and medium dosages of Baoganning went up significantly(P<0.01);The effects of high dosage Baoganning on increasing the levels of TC was greater than colchicines (P<0.05);Baoganning with high and middle dosages was also more effective than colchicines in increasing the levels of TG(P<0.05).
     4.The influence of Baoganning on serum leptin in liver fibrosis rat model.
     Compared with the normal group,levels of leptin in the model group went up noticeably(P<0.01);Compared with the model group,levels of leptin went down obviously(P<0.01,P<0.01,P<0.05)for both Baoganning and colchicines groups with high and middle dosages.
     5.The effects of Baoganning on the expression of Leptin and its signal pathway in liver tissue in fibrosis rat model.
     Only a mild positive staining of leptin was found at central vein and Disse's areas but none at hepatocytes on sections of normal controls,whereas on sections of the model group,the positive staining was seen at interstitial cells,inflammatory cells, impaired hepatocytes as well as normal hepatocytes.Fibrous c septa were only slightly stained.In the treatment groups the positive staining cells decreased and the staining was evidently light.
     Normal liver tissue hardly expressed OB-Rb or only a mild positive staining was found at portal vein,central vein and portal tract.Whereas in the model group OB-Rb mostly was located in the portal tract,around sinusoid and fibrotic septa.Expression of OB-Rb exhibited as brown particles predominantly in cytoplasm or cell membrane.A few positive expressions were found in nucleus.Contrast to the model group,the positive staining cells and the staining degree in the treatment groups were not obviously changed.
     Normal liver tissue hardly expressed Stat3,only a mild positive staining was found at matrix in portal tract and at cytoplasm in interstitial cells,whereas in the model group Smad4 dominated.It was detected in interstitial cells at fibrous septa,portal tract, portal vein,central vein and around sinusoid,especially at fibrous septa.In the treatment groups the number of positive staining cells decreased,mainly expressed at portal tract,portal vein and central vein.
     Statistical data analysis indicated that the expression level of leptin,OB-Rb and Stat3 were increased significantly in the model group(P<0.01).Compared with the model group,the Immunostaining score of leptin in high and middle dosage Baoganning,colchicines groups was remarkably decreased(P<0.01 in both groups), Stat3 was also remarkably decreased(P<0.01,p<0.051 P<0.05).OB-Rb was not noticeably decreased(P>0.05 in all treatment groups).
     6.The effects of Baoganning on the expression of OB-Rb and JAK2-STAT3 signal pathway in liver tissue in fibrosis rat model.
     The expression of OB-Rb,JAK_2,STAT_3 and the activity of phosphor-JAK_2, phosphor-STAT_3 were detected by Western blotting analysis.All of these in normal liver tissue were barely detected,whereas in the model group expressed strongly. Compared with the model group,the expression of them in all treatment groups
     Conclusions:Baoganning can inhibit the process of liver fibrosis in rats model, the mechanisms are as follows.
     1.Baoganning can improve the life quality through improving the spirits, increasing the body weight,food and water intake and decreasing the indices of liver and spleen
     2.Morphological observation shows Baoganning can improve the damaged structure of heptocyte,decrease the fibrosis tissue.
     3.Baoganning can significantly decrease the levels of serum ALT,AST and increase the levels of TC and TG.
     4.Baoganning can reduce the expression of Leptin,OB-Rb and its signal transduction molecule JAK2 and STAT3 in the liver tissue,so the signal transduction pathway of leptin is inhibited by the EHAWE therapy.
     In conclusion,Baoganning has the complicated pharmacological action on preventing the liver fibrosis.It has multi-way and multi-target anti-fibrosis mechanisms.One of the molecular mechanisms is to inhibit the expression of leptin and its signal transduction which is concerned to inhibit the inflammation,protect the liver cell,decrease the waterfall action of the cytokine and inhibit the start of the fibrosis.
引文
铩?.李蕴铷,吕敏和.肝纤维化患者血清白介素-8水平与Child分级的关系.胃肠病Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    学和肝病学杂志,1998,7(4):343 344.Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    
    2.KakumuS,OkumuraA,IshikawaT etal.Serum level sof IL-10,IL-15 andQuery =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    soluble tumor necrosis factor alpha receptors in type C chronic liverQuery =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    disease.Clin ExpImmunol,1997,109(3):458 -463.Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    
    3.朱金水,朱励,余小虎,等.氧化苦参碱对肝纤维化患者IL-6、IL-8、IL-10水Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    平影响.中国免疫学杂志,2003,9(3):191-193Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    
    4.杜荔箐,唐望先,但自力.中药肝炎平防治肝纤维化的实验研究.华人消化杂Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    志,1998,6(1):21.Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    
    5.陈廷玉,王景涛,张波.小柴胡汤抗肝纤维化的形态学和血清学实验研究[J].Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    黑龙江医药科学,2003,26(4):48 49.Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    
    6.时绍红,刘君炎,邓长生.银杏叶提取物抗大鼠肝纤维化的实验研究[J].临床Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    消化病杂志,2004,16(1):15 17.Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    
    7.刘诗权,于皆平,冉宗学.纳康抗肝纤维化作用及其机制的探讨[J].实用医 学杂志,2002,18(6):574 575.
    
    8.张幸国,虞朝辉,秦玉娥,等.茶多酚抗大鼠肝纤维化及其机制研究[J].中国中药杂志,2003,28(11):1070 1072.
    9.王艳芬,潘留兰,苑坤.氧化苦参碱的抗肝纤维化作用及其机制研究[J].中国医师杂志,2004,6(12):1599 1601.
    10.钦丹萍,挺英,任永葆.逐下瘀血汤对实验性肝硬化及其脂质过氧化反应干预研究[J].中国中医药信息杂志,2003,10(3):25 27.
    11.都广礼,武明东.免疫调控对肝纤维化发病机制与防治影响.中医药学刊,2001,19(5):446-447
    12.姚真敏,熊耀康,李剑平.鳖甲煎口服液抗肝纤维化作用的实验研究.浙江中医学院学报,2000,24(1):58-61
    13.张万国,胡晋红,蔡溱桑黄诱生γ-干扰素与抗肝纤维化.中医药报,2002,30(6):22-24.
    14.陈颖伟,卫新革,展玉涛,等.大黄与粉防己碱抗实验性肝纤维化的对照研究.中华消化杂志,2003,23(8):476-477
    15.沈洁云,燕忠生.丹参保肝抗肝纤维化药理作用及应用进展.中西医结合肝病杂志,1998,8(2):124.
    16.雄益群,阎红梅,张赤志.抗纤软肝冲剂抗大鼠肝纤维化的实验研究.中国实验方剂学杂志,2000,6(2):28.
    17.王要军,权启镇,孙自勤,等.复方汉防己治疗实验性肝纤维化的机制探讨.中国中西医结合脾胃杂志,2000,8(3):151-152
    18.郭顺根,张玮,江涛.活血化瘀方药理血清对离体肝星形细胞影响的研究.北京中医药大学学报,2003,26(1):24-25.
    19.陈文慧,王海南,刘成海,等.福尔肝6号对肝星状细胞增殖的影响.云南中医学院学报 2001,24(4):11-12
    20.杨玲,张赤志,朱清静,等.抗纤软肝颗粒对肝星状细胞增殖的影响.中国中西 医结合消化杂志,2002,10(6):323-325.
    
    21.尤红,王宝恩,马雪梅,等。复方861对原代培养大鼠肝细胞增殖和凋亡的作用.中国实验方剂学杂志,2001,7(2):34-35
    22.尤红,王宝恩,王泰玲,等复方861对肝星状细胞增殖和凋亡的干预作用.中华肝脏病杂志,2000,8(2):78
    23.李万平,魏嵋,李华,等.肝毒清颗粒对大鼠实验性肝纤维化的防治作用.四川生理科学杂志.2003;25(2):7
    24.周小舟,贺劲松,徐文军,等.软肝冲剂对肝硬变过程中细胞周期DNA含量的影响.中国中西医结合消化杂志,2003,11(2):93
    25.喻长远,李家邦,郭振球.肝纤宁颗粒对肝纤维化模型大鼠肝细胞的影响.中国中医基础医学杂志.2002,8(2):44-45
    26.方步武,刘平,刘成,等。虫草多糖抗免疫损伤性大鼠肝纤维化的作用及其机理研究。上海中医药杂志,2000,34(9):38-39
    27.王天才,张国,王波.和络舒肝胶囊对大鼠慢性肝损伤的保护作用及分子机制研究.华中科技大学学报(医学版),2002,31(2):171
    28.刘成海,刘平,胡义扬,等.丹酚酸B盐对转化生长因子-β1刺激肝星状细胞活化与胞内信号转导的作用.中华医学杂志,2002,82(18):1267
    29.阴郝宏,马红,王爱民,等.复方861对HSC T6细胞组织基质金属蛋白酶抑制因子1基因表的影响[J].中华肝脏病杂志,2002,10(3):197 199.
    30.杨国汉,戴裕光,钟瑜.肝结散抗肝纤维化治疗中P C Ⅲ、H A、L N的动态变化[J].北京中医药大学学报,2003,26(1):42 44.
    31.赵钢,王灵台,陈建杰,等.抗纤复方含药血清对HSC-LI90细胞基质金属蛋白酶及其抑制因子基因表的影响.中国实验方剂学杂志,2003(9)4:31-33
    32.朱跃科,阴宏,马雪梅,等.实验性肝纤维化模型肝组织MMP-2基因表与酶活性及中药复方“861”的作用.中华实验和临床病毒学杂志,2002,16(4):348-349
    33.刘绍能,姚乃礼,殷海波,等.芪术颗粒对大鼠肝纤维化模型TGF-β1、EGF表 的影响.中药新药与临床药理,2001,17(5):24
    
    34.姚树坤,殷飞,李志辉,等.清肝化瘀口服液对大鼠肝纤维化的治疗作用[J].中国中西医结合脾胃杂志,1998,6(2):101.
    35.朱圣奎,曾一朗,方金泉.中药复方抗胶原散对肝纤维化可逆性的动物实验研究[J].浙江中西医结合杂志,1997,7(1):16.
    36.晏荣,赵聚凯,陈庆平,等.中药复方“健肝”抗大鼠肝纤维化的实验研究[J].中国中医药科技,2000,7(1):12.
    1 刘平.中医药在抗肝纤维化治疗中的优势.中国中西医结合杂志,2002,22(5):328-329
    2 贺松其,吕志平.慢性乙型肝炎辨治规律及用药原则探讨.福建中医药,2002,33(6):43-44
    3 贺松其.慢性乙型肝炎辨治探析.山东中医杂志.2003,22(185):131-132
    4 吕志平,贺松其,张绪富等.保肝宁抗肝纤维化的治疗作用探析.上海中医药杂志,2005,39(5):6
    5 贺松其,张绪富,蔡红兵等.吕志平教授辨治慢性肝炎肝纤维经验介绍.新中医,2005,38(3):16
    6 吕志平.“肝郁”大鼠的脂质过氧化反应及遥散的保护作用.山东中医学院学报,1999,19(3):199-201.
    7 吕志平,刘承才.肝郁动物模型肝细胞线粒体超微结构观察.湖南中医杂志,2000,16(5):61-62.
    8 吕志平,刘承才.“肝郁”大鼠血浆TXA2、PGI2水平与肝微循环变化及遥散作用.中国微循环.2000,4(3):160-161.
    铩? 吕志平,刘强,路新卫.不同浓度氮酮对黄芩苷体外透皮吸收的影响.第一军医Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    大学学报,2002,22(11):1003-1004.Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    
    10 吕志平,刘强,朱红霞.黄芩苷渗透裸鼠皮肤的动力学研究.中国药房,2003,Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    14(6):331-332.Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    
    11 赵进军,吕志平,刘永刚.白背叶根对肝纤维化大鼠的实验研究.现代诊断与Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    治疗,2002,13(5):257-259.Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    
    12 赵进军,吕志平,张绪富.保肝宁对过氧化氢损伤大鼠肝细胞的保护作用.广Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    州中医药大学学报,2002,19(3):211-213.Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    
    13 赵进军,吕志平,张绪富.保肝宁对肝纤维化大鼠的实验研究中国中西医结合Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    杂志2002增刊 162-164.Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    
    14 赵进军,吕志平,张绪富等.肝宁对急性肝细胞损伤过程中NF-kB的影响.Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    中医杂志.2004,45(6):457-458Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    
    15 张绪富,吕志平,周迎春.保肝宁对HSC_T6细胞增殖及I型胶原表的影响.Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    中医药学刊,2003,21(2):207-208.Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    
    16 刘晓燕,吕志平,张绪富.中药复方保肝宁对HSC的促凋亡作用.山东中医杂Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    志,2004,23(5):294-297.Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    
    17 谭焱,吕志平,张绪富.保肝宁对实验性肝纤维化大鼠肝内核转录因子表的Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    影响。中国中西医结合杂志.2005.25(9):804-807Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    
    18 Tan Yan,Lvzhiping.Traditional Chinese medicine bao gan ning increaseQuery =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    phosphorylation of CREB in liver fibrosis in vivo and in vitro.JournalQuery =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    of Ethnopharmacology.2005 Nov 14:69-75
    1.Reeves HL,Friedman SL.Activation of hepatic stellate cells--a key issue in liver fibrosis.Front Biosci.2002;7:d808-26.
    2.Ramadori G,Armbrust T,Cytokine in the liver.Euro J Gastro Hepa,2001,13(7):777-784
    3.戴敏,郭顺根.细胞因子与肝纤维化.解剖科学进展,2003,9(4):236.
    4.Saxena NK,Titus MA,Ding X,et al.Leptin as a novel profibrogenic cytokine in hepatic stellate cells:mitogenesis and inhibition of apoptosis mediated by extracellular regulated kinase(Erk)and Akt phosphorylation.FASEB J.2004;18(13):1612-4.
    5.Lang T,Ikejima K,Yoshikawa M,et al.Leptin facilitates proliferation of hepatic stellate cells through up-regulation of platelet-derived growth factor receptor. Biochem Biophys Res Commun. 2004;323(3):1091-5.
    
    6. Halaas JL, Gajiwla KS, Maffei M et al. Weight reducing effects of the plasma protein encode by the obese gene. Science, 1995, 269:543-6.
    
    7. PicheT, Vandenbos F, Abakar-Mahamat A, et al. The severity of liver fibrosis is associated with high leptin levels in chronic hepatitis C. J Viral Hepat. 2004 ;11(1):91-6.
    
    8. Campillo B, Sherman E, Richardet JP, et al. Serum leptin levels in alcoholic liver cirrhosis: relationship with gender , nutritional status , liver function and energy metabolism. Eur J Clin Nutr. 2001:55(11):980-8.
    
    9. Garcia-Suarez C, Crespo J, Fernandez-Gil PL, et al. Plasma leptin levels in patients with primary biliary cirrhosis and their relationship with degree of fibrosis. Gastroenterol Hepatol. 2004 ;27(2):47-50.
    
    10. Otte C, Otte JM, Strodthoff D , et al. Expression of leptin and leptin receptor during the development of liver fibrosis and cirrhosis. Exp Clin Endocrinol Diabetes. 2004 ;112(1):10-7.
    
    11. Honda H, Ikejima K, Hirose M, Yoshikawa M, et al. Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver.Hepatology. 2002 ;36(1):12-21.
    
    12. Leclercq IA, Farrell GC, Schriemer R, et al. Leptin is essential for the hepatic fibrogenic response to chronic liver injury. J Hepatol. 2002 ; 37 (2): 206-13.
    
    13. Ikejima K, Honda H, Yoshikawa M, et al. Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic
    chemicals.Hepatology.2001;34(2):288-97.
    铩?4.Potter JJ,Womack L,Mezey E,et al.Transdifferentiation of ratQuery =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    hepatic stellate cells results in leptin expression.Biochem Biophys ResQuery =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    Commun 1998;248(2):441.Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    
    15.Cao Q,Mak KM,Ren C,Lieber CS.Leptin stimulates tissue inhibitorQuery =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    of metalloproteinase-1 in human hepatic stellate cells:respective rolesQuery =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    of the JAK/STAT and JAK-mediated H202-dependant MAPK pathways.J BiolQuery =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    Chem.2004;279(6):4292-304.Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    
    16.Saxena NK,Ikeda k,Rockey DC,et al.Leptin in hepatic fibrosis:Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    evidence for increased collagen production in stellate cells and leanQuery =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    littermates of ob/ob mice.Hepatology.2002;35(4):762-71.Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    
    17.赵进军,吕志平,张绪富.核转录因子在肝星状细胞激活中的作用.中华肝脏Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    病杂志,2002,10(3):227Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    
    18.赵宗豪.核因子κ B与肝纤维化的研究进展.实用肝脏病杂志,2004,Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    7(2):119Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    
    19.Madrid LV,Mayo MW,Reuther JY,et al.Akt stimulates theQuery =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    transactivation potential of the RelA/p65 Subunit of NF-kappa B throughQuery =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    utilization of the Ikappa B kinase and activation of theQuery =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    mitogen-activated protein kinase p38.J Biol Chem.Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    2001;276(22):18934-40.Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    
    20.Karin M,Lin A.NF-kappaB at the crossroads of life and death.NatQuery =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    Immunol.2002;3(3):221-7.Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    
    21.刘平.中医药在抗肝纤维化治疗中的优势.中国中西医结合杂志,2002,Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    22(5):328-329
    22.谢艳爽,郭顺根.血小板衍生生长因子在肝星状细胞内的信号转导.中国组织化学与细胞化学杂志,2004,3(3):323
    23.赵进军,吕志平,张绪富.保肝宁对肝纤维化的动物实验研究.中国中西医结合杂志.2002年增刊:162-164.
    24.赵进军,吕志平,刘永刚,等.保肝宁对过氧化氢损伤大鼠肝细胞的保护作用.广州中医药大学学报,2002:19(3):211-213
    25.张绪富,吕志平,周迎春,等.保肝宁对HSC-T_6细胞增殖及I型胶原表的影响.中医药学刊,2003,21(2):207
    26.刘晓燕,吕志平,张绪富,等.保肝宁对肝星状细胞的促凋亡作用.山东中医,2004,23(5):294
    27.刘晓燕,吕志平,张绪富,等.保肝宁对HSC中NF-kB影响的实验研究.陕西中医,2004,25(6):569
    铩?.李召忠,王啸,隋在云,等.血隆冲剂抗肝纤维化的临床与实验研究[J].中国Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    中西医结合杂志,2001,21(11):814Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    
    2.叶放.肝纤维化病因病机证治指要[J].中医药学刊,2005,20(3):339Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    
    3.汪寿鹏.病毒性肝炎辨证分型与血清TBIL、TTT、ALT指标关系的观察[J].江苏Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    中医,1997,18(1):12-13.Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    
    4.吴淑琼,等.肝纤维化指标与中医辨证分型的关系[J].中西医结合肝病杂志Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    志,2000,10(2):48-49.Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    
    5.贺松其,吕志平.慢性乙型肝炎辨治规律及用药原则探讨.福建中医药,2002,Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    33(6):43-44Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    
    6.贺松其.慢性乙型肝炎辨治探析.山东中医杂志.2003,22(185):131-132Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    
    7.吕志平,贺松其,张绪富等.保肝宁抗肝纤维化的治疗作用探析.上海中医药杂Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    志,2005,39(5):6Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    
    8.贺松其,张绪富,蔡红兵等.吕志平教授辨治慢性肝炎肝纤维经验介绍.新中Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    医.2005.38(3):16
    9.Jiang Z,You DY,Chen XC et al.Monitoring of serum markers for fibrosis during CCl_4-induced liver damage.Effects of anti-fibrotic agents[J].J Hepatol.1992;16(3):282-9.
    10.曾林,王慧芳,胡仲明.肝纤维化动物模型的研究进展[J].动物医学进展,2003:24(6):52-4
    11.叶百宽.中医肝脏生理病理的现代实验研究述评[J].北京中医药大学学报,1996,19(3):5
    1.病毒性肝炎病理组织学诊断标准[J].中华病理学志,1996,25(2):122-123.
    2.Friedman SL.Molecular mechanisms of hepatic fibrosis and principles of therapy[J].J Gastroenterol.1997;32(3):424-30.
    3.沈秀华.凋亡和肝纤维化.国外医学.生理.病理科学与临床分册[J].2002,22(4):349-350
    4.Shi J,Aisaki K,Ikawa Y,et al.Evidence of hepatocyte apoptosis in rat liver after the administration of carbon tetrachloride[J].Am J Pathol.1998 Aug;153(2):515-25.
    5.GressnerAM,BachemMG.Molecular mechanisms of liber fibrogenesis ahomage to the role of actibated fat-storin cells[J].Digestion,1995,56(6):335-346
    6.Tribble DL,Aw TY,jones DP.The pathophysiological significance of lipid peroxidation in oxidative cell in jury[J].Hepatology.1987;7(2):377-86.
    7.Reeves HL,Friedman SL.Activation of hepatic stellate cells--a key issue in liver fibrosis[J].Front Biosci.2002;7:d808-26.
    8.Wu J,Zern MA.Hepatic stellate cells:a target for the treatment of liver fibrosis[J].J Gastroenterol.2000;35(9):665-72.
    1.俞利平,陈小囡,方志明.丹参注射液对大鼠酒精性肝损伤血清ALT、AST的影响[J].中国中医基础医学杂志,2004,10(7):63
    2.梁扩寰,李绍白.肝脏病学[M].北京:人民卫生出版社,1995.208
    3.陈祝英,郑屏唐.慢性肝炎转氨酶与肝组织形态定量的关系.临床肝胆杂志,1998,14(1):47
    4.王英,贾杰.AST/ALT比值在各种肝病中的变化和意义.中国热带医学,2001,1(3):222
    5.Giannini E,Botta F,Fasoli A,et al.Progressive liver functional impairment 15 associated with an increase in AST/ALT ratio.Dig Dis Sci,1999,44:1249-1253.
    6.Bonacini M,Hadi G,Govindarajan S,et al.Utility of a discriminant score for diagnosingadvanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection[J].Am J Gastroenterol.1997.92:1302-1304.
    7.宋育林,杨文卓,贾一滔,等.慢性肝病病理分级、分期与血清学指标关系的初步研究.胃肠病学,2001,6(2):78
    8.黄诒森,主编.生物化学.北京:人民卫生出版社,2001,133.
    9.叶应妩,王毓三,主编.全国临床检验操作规程.北京:人民卫生出版 社,1997,271-272.
    
    10.吴文菊 韩启慧 张孝永肝纤维化患者血脂检测的临床意义 青海医药杂志2006,36(11):35-36.
    铩?.宋振河.瘦素在肝脏发生中作用机制的研究进展[J].实用肝脏病杂Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    志,2005,8(4):239.Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    
    2.SpiegelmamBM,FlierJS.Obesity and dregulation of eneagyQuery =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    blance[J].Cell,2001,104(4):531.Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    
    3.AhimaRS,ElierJS,Leeptin,AnaaRevPhsiol,2000,62:413.Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    
    4.FlurnnMC,PlataSalamanCR.Leptin(Obprotein)andQuery =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    mealsize[J].Nutrition,1997,15:508.Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    
    5.Halaas JL,Gajiwla KS,Maffei M et al.Weight reducing effects of theQuery =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    plasma protein encode by the obese gene.Science,1995,269:543-6.Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    
    6.Piche T,Vandenbos F,Abakar-Mahamat A,et al.The severity of liverQuery =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    fibrosis is associated with high leptin levels in chronic hepatitis C.J Viral Hepat. 2004 ;11(1):91~6.
    
    7.Campillo B, Sherman E, Richardet JP, et al. Serum leptin levels in alcoholic liver cirrhosis: relationship with gender, nutritional status , liver function and energy metabolism. Eur J Clin Nutr. 2001;55(11):980-8.
    
    8. Garcia-Suarez C, Crespo J, Fernandez-Gil PL, et al. Plasma leptin levels in patients with primary biliary cirrhosis and their relationship with degree of fibrosis. Gastroenterol Hepatol. 2004 ;27(2):47-50.
    
    9. Otte C, Otte JM, Strodthoff D , et al. Expression of leptin and leptin receptor during the development of liver fibrosis and cirrhosis. Exp Clin Endocrinol Diabetes. 2004 ;112(1):10-7.
    
    10. Honda H, Ikejima K, Hirose M, Yoshikawa M, et al. Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver. Hepatology. 2002 ;36(1):12-21.
    
    11. Leclercq IA, Farrell GC, Schriemer R, et al. Leptin is essential for the hepatic fibrogenic response to chronic liver injury. J Hepatol. 2002 ; 37 (2): 206-13.
    
    12. Ikejima K, Honda H, Yoshikawa M, et al. Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals. Hepatology. 2001 ;34(2):288-97.
    
    13. axena NK, Titus MA, Ding X, et al. Leptin as a novel profibrogenic cytokine in hepatic stellate cells: mitogenesis and inhibition of apoptosis mediated by extracellular regulated kinase (Erk) and Akt phosphorylation. FASEB J. 2004;18(13):1612-4.
    
    14. ang T, Ikejima K, Yoshikawa M, et al. Leptin facilitates proliferation of hepatic stellate cells through up-regulation of
    platelet-derived growth factor receptor.Biochem Biophys Res Commun.
    2004;323(3):1091-5.
    铩?5 邢亚威,秦玉彩 肝硬化患者血清瘦素水平测定的临床意义及其与骨代Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    谢指标的关系 临床荟萃 2006;21(4):257-259.
    1.StorrM,AllescherHD[J]DisEsophagus,1999,12(4):241 257
    2.Gide on RM,CastellDO,YarzeJ,etal[J]DigDisSci,1999,44(9):1853 1857
    3.RajputS,NandwaniSk,PhadkeAY,etal[J]ImdianJGastroenterol,2000,19(3):126 129
    4.BorottoE,GandricM,DanelB,etal[J]Gut,1996,399(1):912
    5.Ihle JN et al.Cell,1996;84:331-334
    6.Darnell JE et al.Science,1994;264:1415-1419
    7.SanchezMargletV,MartinRomeroC,GonzalezYanesC,etal.Leptinreceptor(O bR)expressionisincludedinperipheralbloodmononuclearcellsbyinvitroact ivationandinvivoinHIVinfectedpatients.ClinExpImmunol,2002,129(1):119-124
    8.Saxena NK,Ikeda k,Rockey DC,et al.Leptin in hepatic fibrosis:evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice.Hepatology.2002;35(4):762-71.
    9.IkejimaK,TakeiY,HondaH,etal.Leptin receptor mediated signaling regulate shepaticfibrogenesisandrenodeling of extra cell lularmatrixintherat.Gastroenterology,2002,122(5):1399-1410
    10.Otte C,Otte JM,Strodthoff D,et al.Expression of leptin and leptin receptor during the development of liver fibrosis and cirrhosis.Exp Clin
    Endocrinol Diabetes.2004;112(1):10-7.
    铩?1.TangM,PotterJJ,MezeyE.Leptin enhances the effect of transformingQuery =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    growthfactorbetainincreasingtypeIcollagenformation.BiochemBiophysResQuery =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    Commun,2002,297(4):906-911Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    
    12.Ikejima K,Honda H,Yoshikawa M,et al.Leptin augments inflammatoryQuery =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    and profibrogenic responses in the murine liver induced by hepatotoxicQuery =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    chemicals.Hepatology.2001;34(2):288-97.Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    
    13.Saxena NK,Titus MA,Ding X,et al.Leptin as a novel profibrogenicQuery =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    cytokine in hepatic stellate cells:mitogenesis and inhibition ofQuery =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    apoptosis mediated by extracellular regulated kinase(Erk)and AktQuery =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    phosphorylation.FASEB J.2004;18(13):1612-4.Query =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    
    14.Wang MY,Zhou YT,Newgard CB,etal.A novel leptin receptor isoformQuery =
    CADORecordset Error
     Code = 80040e31
     Code meaning = IDispatch error #3121
     Source = Microsoft OLE DB Provider for SQL Server
     Description = 超时已过期
    in rat.FEBS Lett,1996,392:87-90
    1.Darnell JJ,Kerr IM,Stark GR,et al.Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins[J].Science,1994,264:1415-1421.
    2.Aaronson DS,Horvath CM.A road map for those who don' t know JAK-STAT[J].Science,2002,296:1653-1655.
    3.Zhang X,Darnell JE.Functional importance of Star3 tetramerization in activation of the alpha 2-macroglobulin gene[J].J Biol Chem,2001,276:33576-33581.
    4.Kisseleva T,Bhattcharya S,Schindler CW,et al.Signal through the Jak-STAT pathway,recent advances and future challenges[J].Gene,2002,285:1-24.
    5.Ram PT,Iyengar RG.Protein coupled receptor signaling through the Src and star3 pathway:role in proliferation and transformation[J].Oncogene,2001,20:1601.
    6.Catlett-Falcone R,landiwski TH,Oshiro MM,et al.Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells[]J.Immunity,1999,10:105-115.
    7.Chapman RS,Lourenco PC,Tonner E,et al.Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3[J]. Genes Dev, 1999, 13: 2604-2616.
    
    8. Fukada T, Ohtani T, Yoshida Y, et al. STAT3 orchestrates contradictory signals in cytokine-induced G1 to S cell-cycle transition[J]. EMBO J, 1998, 17: 6670-6677.
    
    9. Shirogane T, Fukada T, Muller JMM, et al. Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis[J]. Immunity, 1999, 11: 709-719.
    
    10. Booz GW, Day JNE, Baker KM. Interplay between the cardiac renin angiotensin system and JAK-STAT signaling: Role in cardiac hypertrophy, ischemia/reperfusion dysfunction, and heart failure. J Mol Cell Cardiol, 2002, 34: 443-1453.
    
    11. Xuan YT, Guo Y, Han H, et al. An essential role of the JAK-STAT pathway in ischemic preconditioning. Proc Natl Acad Sci U S A, 2001, 98: 9050-9055.
    
    12.Mascareno E, El-Shafei M, Maulik N, et al. JAK-STAT signaling is associated with cardiac dysfunction during ischemia and reperfusion. Circulation, 2001, 104: 325-329.
    
    13. Vaisse C, Halaas JL, Horvath CM, et al Leptin activation of STAT3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice [J].NatGenet 1996,14(1) :95-97.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700